Resources - Search Results | Barrington James

Back to resources

Displaying 1 - 8 of 157

Pharmaceutical
Rapid Delivery of a Safety Science Lead for a Critical Oncology Programme
Barrington James partnered with a Swedish biopharmaceutical company to deliver a Safety...

By Alex Cooper April 2nd, 2026
Q1 2026 Conference Round-Up: Key Insights Across Life Sciences & Quantum
From San Diego to Denver, London to Lisbon, Q1 2026 saw our team on the ground at some of th...

By Barrington James March 31st, 2026
https://sitescdn.wearevennture.co.uk/public/barrington-james/assets/blog-cover-images--4--4af7ba197ead4f86baa635f98d8f9712.webp

2026 Quantum Salary Benchmarking Guide
Access the latest salary insights shaping the quantum talent market in 2026 with our in-dept...

By Richard Stevenson March 31st, 2026
Biotechnology, Medical Device
Q2 Boardroom Reckoning: What Q1 Made Clear
Amid breakthrough discovery, digital transformation, and shifting regulation, life sciences ...

By Barrington James March 31st, 2026
Pharmaceutical, Consulting
Clinical Development Lead Placement for a Rare Paediatric Disease Programme
Barrington James partnered with an established biopharmaceutical client to deliver a Clinica...

By Bobby Coxon March 24th, 2026
Biotechnology
Why the Latest IPO Wave Won’t Be Won on Science Alone.
IPO activity does more than unlock capitalIn the last cycle, the path to public markets was ...

By Barrington James March 20th, 2026
The Peptide Shift Is a Stress Test for 503B Infrastructure
Over the weekend, HHS Secretary Robert F. Kennedy Jr. publicly stated an intent to move appr...

By Ethan Dumoulin March 12th, 2026
Biotechnology
Navigating Cell & Gene Therapy Hiring Trends and the 2026 Outlook.
Market Context: From Breakthrough Momentum to Operational Discipline When the fir...

By Brandon Schelkle March 12th, 2026